Bioventus Inc
BVS6.480USD
+0.300+4.85%
Market hours （ET）Quotes delayed by 15 min
429.18MMarket Cap
LossP/E TTM
More Details of Bioventus Inc Company
Bioventus Inc. is a medical device company. The Company is focused on developing and commercializing clinically differentiated and minimally invasive treatments that engage and enhance the body’s natural healing process. Its portfolio of products is grouped into three areas. Its Pain Treatments include non-surgical pain injection therapies as well as peripheral nerve stimulation (PNS) products to help the patient get back to their normal activities. Its Surgical Solutions include bone graft substitutes (BGS) that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries, as well as a portfolio of ultrasonic products used for precise bone cutting and sculpting, soft tissue management and tissue debridement in various surgeries. Its Restorative Therapies comprise a bone stimulation system, as well as devices designed to help patients regain leg or hand function due to stroke, multiple sclerosis or other central nervous system disorders.
Company Info
Ticker SymbolBVS
Company nameBioventus Inc
IPO dateFeb 11, 2021
CEOMr. Robert E. Claypoole
Number of employees930
Security typeOrdinary Share
Fiscal year-endFeb 11
Address4721 Emperor Boulevard, Suite 100
CityDURHAM
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code27703
Phone19194746700
Websitehttps://www.bioventus.com/
Ticker SymbolBVS
IPO dateFeb 11, 2021
CEOMr. Robert E. Claypoole
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Anthony D'adamio, J.D.
Mr. Anthony D'adamio, J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
134.37K
+7.98%
Ms. Susan M. Stalnecker
Ms. Susan M. Stalnecker
Independent Director
Independent Director
105.96K
+33.34%
Mr. Guy Paul Nohra
Mr. Guy Paul Nohra
Independent Director
Independent Director
100.12K
--
Mr. Guido J. Neels
Mr. Guido J. Neels
Independent Director
Independent Director
85.24K
+45.10%
Mr. John A. Bartholdson
Mr. John A. Bartholdson
Independent Director
Independent Director
79.62K
+74.79%
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
Independent Director
Independent Director
76.44K
+53.05%
Ms. Michelle Mcmurry-Heath, M.D., Ph.D.
Ms. Michelle Mcmurry-Heath, M.D., Ph.D.
Independent Director
Independent Director
74.70K
+54.96%
Mr. Philip G. Cowdy
Mr. Philip G. Cowdy
Independent Director
Independent Director
11.70K
--
Mr. Mark Singleton
Mr. Mark Singleton
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
--
--
Ms. Katrina Church, J.D.
Ms. Katrina Church, J.D.
Senior Vice President, Chief Compliance Officer
Senior Vice President, Chief Compliance Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Anthony D'adamio, J.D.
Mr. Anthony D'adamio, J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
134.37K
+7.98%
Ms. Susan M. Stalnecker
Ms. Susan M. Stalnecker
Independent Director
Independent Director
105.96K
+33.34%
Mr. Guy Paul Nohra
Mr. Guy Paul Nohra
Independent Director
Independent Director
100.12K
--
Mr. Guido J. Neels
Mr. Guido J. Neels
Independent Director
Independent Director
85.24K
+45.10%
Mr. John A. Bartholdson
Mr. John A. Bartholdson
Independent Director
Independent Director
79.62K
+74.79%
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
Independent Director
Independent Director
76.44K
+53.05%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Pain Treatments and Joint Preservation
58.92M
47.56%
Surgical solutions
45.23M
36.52%
Restorative Therapies
19.72M
15.92%
By RegionUSD
Name
Revenue
Proportion
United States
110.52M
89.22%
International
13.36M
10.78%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Pain Treatments and Joint Preservation
58.92M
47.56%
Surgical solutions
45.23M
36.52%
Restorative Therapies
19.72M
15.92%
Shareholding Stats
Updated: Sat, May 17
Updated: Sat, May 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
EW Healthcare Partners
19.62%
Juniper Investment Company, LLC
10.46%
Smith & Nephew Group plc
9.39%
Nantahala Capital Management, LLC
6.22%
BlackRock Institutional Trust Company, N.A.
3.85%
Other
50.46%
Shareholders
Shareholders
Proportion
EW Healthcare Partners
19.62%
Juniper Investment Company, LLC
10.46%
Smith & Nephew Group plc
9.39%
Nantahala Capital Management, LLC
6.22%
BlackRock Institutional Trust Company, N.A.
3.85%
Other
50.46%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
24.76%
Venture Capital
19.62%
Investment Advisor
16.38%
Hedge Fund
9.46%
Corporation
9.39%
Individual Investor
2.56%
Research Firm
1.23%
Bank and Trust
0.33%
Pension Fund
0.21%
Other
16.06%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
315
55.71M
83.95%
-8.66M
2025Q1
320
55.18M
83.57%
-8.66M
2024Q4
318
53.79M
82.30%
-10.70M
2024Q3
319
53.14M
81.61%
-8.49M
2024Q2
288
54.91M
84.63%
-3.42M
2024Q1
287
52.64M
83.27%
-7.74M
2023Q4
285
51.63M
82.02%
-9.27M
2023Q3
276
51.61M
82.33%
-9.01M
2023Q2
273
50.56M
81.06%
-10.51M
2023Q1
271
49.55M
80.44%
-9.36M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
EW Healthcare Partners
13.02M
19.62%
--
--
Mar 31, 2025
Juniper Investment Company, LLC
6.94M
10.46%
--
--
Mar 31, 2025
Smith & Nephew Group plc
6.23M
9.39%
--
--
Apr 07, 2025
Nantahala Capital Management, LLC
4.13M
6.22%
+98.84K
+2.45%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
2.56M
3.85%
-7.24K
-0.28%
Mar 31, 2025
The Vanguard Group, Inc.
2.55M
3.84%
+92.14K
+3.76%
Mar 31, 2025
Divisadero Street Capital Management, LP
1.69M
2.55%
+1.69M
--
Mar 31, 2025
Driehaus Capital Management, LLC
1.45M
2.18%
+325.40K
+29.06%
Mar 31, 2025
American Century Investment Management, Inc.
1.04M
1.57%
+159.54K
+18.03%
Mar 31, 2025
Fidelity Management & Research Company LLC
998.35K
1.5%
+29.40K
+3.03%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
Harbor Human Capital Factor US Small Cap ETF
0.17%
Lattice Hartford Multifactor Small Cap ETF
0.12%
VictoryShares Small Cap Free Cash Flow ETF
0.09%
Vanguard US Multifactor ETF
0.08%
Fidelity Enhanced Small Cap ETF
0.08%
iShares Micro-Cap ETF
0.07%
Avantis US Small Cap Value ETF
0.04%
Humankind US Stock ETF
0.03%
WisdomTree US SmallCap Fund
0.03%
Avantis US Small Cap Equity ETF
0.03%
View more
Harbor Human Capital Factor US Small Cap ETF
Proportion0.17%
Lattice Hartford Multifactor Small Cap ETF
Proportion0.12%
VictoryShares Small Cap Free Cash Flow ETF
Proportion0.09%
Vanguard US Multifactor ETF
Proportion0.08%
Fidelity Enhanced Small Cap ETF
Proportion0.08%
iShares Micro-Cap ETF
Proportion0.07%
Avantis US Small Cap Value ETF
Proportion0.04%
Humankind US Stock ETF
Proportion0.03%
WisdomTree US SmallCap Fund
Proportion0.03%
Avantis US Small Cap Equity ETF
Proportion0.03%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
